158 results
Page 7 of 8
POS AM
m5ceqx1f2yv5kn8z
22 Apr 20
Prospectus update (post-effective amendment)
5:05pm
POS AM
dl7v ahy07s
22 Apr 20
Prospectus update (post-effective amendment)
5:04pm
S-3
jxm22opjyev5xppu9and
22 Apr 20
Shelf registration
5:02pm
8-K
EX-99.1
z404e 0oyb2
6 Feb 20
Other Events
5:10pm
8-K
EX-10.2
opn93a
16 Dec 19
Entry into a Material Definitive Agreement
6:02am
DEF 14A
ix7givq bo5v8p4z
8 Jul 19
Definitive proxy
4:06pm
8-K
EX-10.1
6a9cl1
8 Jul 19
Entry into a Material Definitive Agreement
4:04pm
424B3
48b8r
2 Apr 19
Prospectus supplement
6:19am
8-K
EX-10.1
f1m av3kjbi7e7om7t
26 Mar 19
Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer
9:16am
8-K
EX-99.1
jngdfg
26 Mar 19
Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer
9:16am
8-K
EX-1.1
dxzzn3oofva
26 Feb 19
Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
8:10am
8-K
EX-99.2
ahijsy2955
26 Feb 19
Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
8:10am
8-K
EX-4.2
ol9wlgowvb7qg
26 Feb 19
Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
8:10am
8-K
EX-99.1
3ny4vbkt ofmzn
26 Feb 19
Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
8:10am
424B4
k6z23
22 Feb 19
Prospectus supplement with pricing info
4:06pm